Adalat and Avodart drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adalat (nifedipine) and Avodart (dutasteride). Common drug interactions include dermatitis exfoliative among males.

The phase IV clinical study analyzes what interactions people have when they take Adalat and Avodart. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Avodart?

Avodart has active ingredients of dutasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 16,428 Avodart users. Check the latest studies of Avodart.



On Aug, 09, 2026

29 people who take Adalat and Avodart together, and have interactions are studied.

Adalat and Avodart drug interactions.

What are the common drug interactions of Adalat and Avodart, by gender? *:

female:

n/a

male:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Pneumonia
  3. Gait disturbance
  4. Haemorrhagic diathesis (bleeding tendency)
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Myositis (inflammation of the muscles)
  7. Pruritus (severe itching of the skin)
  8. Renal failure (kidney dysfunction)
  9. Weight decreased
  10. Wound haemorrhage (bleeding wound)

What are the common drug interactions of Adalat and Avodart, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pneumonia
  2. Chest pain
  3. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Tendon pain
  3. Pneumonia
  4. Pruritus (severe itching of the skin)
  5. Renal failure (kidney dysfunction)
  6. Weight decreased
  7. Haematochezia (passage of stools containing blood)
  8. Insomnia (sleeplessness)
  9. Pain
  10. Activities of daily living impaired

What are the existing conditions these people have? *

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 24.14%
  2. Type 2 Diabetes: 4 people, 13.79%
  3. Prostatic Disorder: 3 people, 10.34%
  4. High Blood Cholesterol: 3 people, 10.34%
  5. Diabetes: 3 people, 10.34%
  6. Chronic Kidney Disease: 3 people, 10.34%
  7. Renal Cancer Metastatic (cancer of kidney spreads to other part): 2 people, 6.90%
  8. Pneumonia: 2 people, 6.90%
  9. Multiple Myeloma (cancer of the plasma cells): 2 people, 6.90%
  10. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and Avodart?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adalat and Avodart:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avodart:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avodart and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine and dutasteride (the active ingredients of Adalat and Avodart, respectively), and Adalat and Avodart (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: